Detalles de la búsqueda
1.
ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy.
Cancer Cell Int;
24(1): 8, 2024 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38178183
2.
Macrophage Profiling in Head and Neck Cancer to Improve Patient Prognosis and Assessment of Cancer Cell-Macrophage Interactions Using Three-Dimensional Coculture Models.
Int J Mol Sci;
24(16)2023 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37628994
3.
Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies.
Cells;
12(14)2023 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37508519
4.
The benefit of co-targeting PARP-1 and c-Met on the efficacy of radiotherapy in wild type BRAF melanoma.
Front Med (Lausanne);
10: 1149918, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37215708
5.
Correction: Krayem et al. The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. Cancers 2019, 11, 1093.
Cancers (Basel);
15(24)2023 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38136445
6.
The electrochemical corrosion behaviour of compacted (Bi, Pb)-2223 superconductors in aqueous solutions.
Sci Rep;
12(1): 17941, 2022 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36289428
7.
Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma.
Cells;
11(7)2022 03 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35406721
8.
Development of fluorizoline analogues as prohibitin ligands that modulate C-RAF signaling, p21 expression and melanogenesis.
Eur J Med Chem;
242: 114635, 2022 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35988448
9.
Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance.
Cells;
11(22)2022 11 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36429091
10.
RTK Inhibitors in Melanoma: From Bench to Bedside.
Cancers (Basel);
13(7)2021 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33918490
11.
Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.
Mol Cancer Res;
19(7): 1221-1233, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33741716
12.
Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value.
Front Oncol;
11: 780654, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34869032
13.
Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis.
Cancers (Basel);
12(5)2020 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32455924
14.
Toad Venom Antiproliferative Activities on Metastatic Melanoma: Bio-Guided Fractionation and Screening of the Compounds of Two Different Venoms.
Biology (Basel);
9(8)2020 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32785105
15.
Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. Cancers 2020, 12, 512.
Cancers (Basel);
12(10)2020 10 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33066704
16.
Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance.
Cancers (Basel);
12(2)2020 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32098410
17.
Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma.
Nat Cell Biol;
22(8): 986-998, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32753671
18.
The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma.
Cancers (Basel);
11(8)2019 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31374895
19.
Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma.
Oncotarget;
9(61): 31888-31903, 2018 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30159130
20.
Targeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cells.
Eur J Med Chem;
155: 880-888, 2018 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29960207